The aim of our study was to evaluate the concentration changes in the proangiogenic hepatocyte growth factor and antiangiogenic endostatin during the sampling of large bone marrow volumes in patients with multiple myeloma.
The aim of our study was to evaluate the concentration changes in the proangiogenic hepatocyte growth factor and antiangiogenic endostatin during the sampling of large bone marrow volumes in patients with multiple myeloma. (en)